Golam Mohi, PhD (IMAGE) University of Virginia Health System Caption Pioneering research led by UVA Cancer Center's Golam Mohi, PhD, into the chronic inflammation often seen in certain blood cancers has identified a promising treatment approach for myelofibrosis, a potentially deadly bone marrow cancer. Credit UVA Health Usage Restrictions May only be used with this release. License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.